Disorders of gastrointestinal systems and clinical manifestations /:
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
New York :
Nova Biomedical,
[2016]
|
Schriftenreihe: | Digestive diseases--research and clinical developments series.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | 1 online resource |
Bibliographie: | Includes bibliographical references and index. |
ISBN: | 9781634853774 1634853776 |
Internformat
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn957997445 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 160503s2016 nyu ob 001 0 eng | ||
010 | |a 2019716120 | ||
040 | |a DLC |b eng |e rda |e pn |c DLC |d EBLCP |d N$T |d YDX |d AGLDB |d SNK |d DKU |d AUW |d INTCL |d MHW |d BTN |d IGB |d D6H |d VTS |d AU@ |d G3B |d S8J |d S9I |d STF |d VLY |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCF |d OCLCO | ||
019 | |a 961204944 | ||
020 | |a 9781634853774 |q (pdf) | ||
020 | |a 1634853776 | ||
020 | |z 9781634853668 |q (hardcover) | ||
020 | |z 1634853660 |q (hardcover) | ||
035 | |a (OCoLC)957997445 |z (OCoLC)961204944 | ||
050 | 0 | 0 | |a RC801 |
060 | 4 | |a WI 140 | |
072 | 7 | |a HEA |x 039000 |2 bisacsh | |
072 | 7 | |a MED |x 014000 |2 bisacsh | |
072 | 7 | |a MED |x 022000 |2 bisacsh | |
072 | 7 | |a MED |x 112000 |2 bisacsh | |
072 | 7 | |a MED |x 045000 |2 bisacsh | |
082 | 7 | |a 616.3/3 |2 23 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Disorders of gastrointestinal systems and clinical manifestations / |c Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors. |
264 | 1 | |a New York : |b Nova Biomedical, |c [2016] | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file | ||
490 | 1 | |a Digestive diseases--research and clinical developments | |
504 | |a Includes bibliographical references and index. | ||
588 | 0 | |a Print version record. | |
505 | 0 | |a DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis | |
505 | 8 | |a 2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES | |
505 | 8 | |a RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD) | |
505 | 8 | |a 1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP | |
505 | 8 | |a 5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES | |
650 | 0 | |a Gastrointestinal system |x Diseases |x Pathophysiology. | |
650 | 0 | |a Gastrointestinal system |x Diseases. |0 http://id.loc.gov/authorities/subjects/sh85053488 | |
650 | 2 | |a Gastrointestinal Diseases |x physiopathology |0 https://id.nlm.nih.gov/mesh/D005767Q000503 | |
650 | 2 | |a Gastrointestinal Diseases |0 https://id.nlm.nih.gov/mesh/D005767 | |
650 | 6 | |a Tractus gastro-intestinal |x Maladies. | |
650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
650 | 7 | |a Gastrointestinal system |x Diseases |2 fast | |
700 | 1 | |a Rajagopal, Senthilkumar, |e editor. | |
700 | 1 | |a Murugan, Sengottuvelan, |e editor. | |
700 | 1 | |a Ramachandran, Saravanan, |e editor. | |
758 | |i has work: |a Disorders of Gastrointestinal Systems and Clinical Manifestations (Text) |1 https://id.oclc.org/worldcat/entity/E39PD3fGpMc7qRTDCqYwJhDqpP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t Disorders of gastrointestinal systems and clinical manifestations. |d New York : Nova Biomedical, [2016] |z 9781634853668 |w (DLC) 2016940560 |
830 | 0 | |a Digestive diseases--research and clinical developments series. |0 http://id.loc.gov/authorities/names/n2010183264 | |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345681 |3 Volltext |
938 | |a ProQuest Ebook Central |b EBLB |n EBL4691155 | ||
938 | |a EBSCOhost |b EBSC |n 1345681 | ||
938 | |a YBP Library Services |b YANK |n 13052454 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn957997445 |
---|---|
_version_ | 1816882360633786369 |
adam_text | |
any_adam_object | |
author2 | Rajagopal, Senthilkumar Murugan, Sengottuvelan Ramachandran, Saravanan |
author2_role | edt edt edt |
author2_variant | s r sr s m sm s r sr |
author_facet | Rajagopal, Senthilkumar Murugan, Sengottuvelan Ramachandran, Saravanan |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RC801 |
callnumber-raw | RC801 |
callnumber-search | RC801 |
callnumber-sort | RC 3801 |
callnumber-subject | RC - Internal Medicine |
collection | ZDB-4-EBA |
contents | DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis 2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD) 1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP 5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES |
ctrlnum | (OCoLC)957997445 |
dewey-full | 616.3/3 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.3/3 |
dewey-search | 616.3/3 |
dewey-sort | 3616.3 13 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06116cam a2200745 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn957997445</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">160503s2016 nyu ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2019716120</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DLC</subfield><subfield code="d">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">YDX</subfield><subfield code="d">AGLDB</subfield><subfield code="d">SNK</subfield><subfield code="d">DKU</subfield><subfield code="d">AUW</subfield><subfield code="d">INTCL</subfield><subfield code="d">MHW</subfield><subfield code="d">BTN</subfield><subfield code="d">IGB</subfield><subfield code="d">D6H</subfield><subfield code="d">VTS</subfield><subfield code="d">AU@</subfield><subfield code="d">G3B</subfield><subfield code="d">S8J</subfield><subfield code="d">S9I</subfield><subfield code="d">STF</subfield><subfield code="d">VLY</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">961204944</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634853774</subfield><subfield code="q">(pdf)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634853776</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781634853668</subfield><subfield code="q">(hardcover)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1634853660</subfield><subfield code="q">(hardcover)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)957997445</subfield><subfield code="z">(OCoLC)961204944</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">RC801</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WI 140</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.3/3</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Disorders of gastrointestinal systems and clinical manifestations /</subfield><subfield code="c">Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Biomedical,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Digestive diseases--research and clinical developments</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Pathophysiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85053488</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Gastrointestinal Diseases</subfield><subfield code="x">physiopathology</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D005767Q000503</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Gastrointestinal Diseases</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D005767</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tractus gastro-intestinal</subfield><subfield code="x">Maladies.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rajagopal, Senthilkumar,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Murugan, Sengottuvelan,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramachandran, Saravanan,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Disorders of Gastrointestinal Systems and Clinical Manifestations (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PD3fGpMc7qRTDCqYwJhDqpP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Disorders of gastrointestinal systems and clinical manifestations.</subfield><subfield code="d">New York : Nova Biomedical, [2016]</subfield><subfield code="z">9781634853668</subfield><subfield code="w">(DLC) 2016940560</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Digestive diseases--research and clinical developments series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010183264</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345681</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4691155</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1345681</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">13052454</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-ocn957997445 |
illustrated | Not Illustrated |
indexdate | 2024-11-27T13:27:23Z |
institution | BVB |
isbn | 9781634853774 1634853776 |
language | English |
lccn | 2019716120 |
oclc_num | 957997445 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource |
psigel | ZDB-4-EBA |
publishDate | 2016 |
publishDateSearch | 2016 |
publishDateSort | 2016 |
publisher | Nova Biomedical, |
record_format | marc |
series | Digestive diseases--research and clinical developments series. |
series2 | Digestive diseases--research and clinical developments |
spelling | Disorders of gastrointestinal systems and clinical manifestations / Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors. New York : Nova Biomedical, [2016] 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier data file Digestive diseases--research and clinical developments Includes bibliographical references and index. Print version record. DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis 2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD) 1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP 5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES Gastrointestinal system Diseases Pathophysiology. Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Gastrointestinal Diseases physiopathology https://id.nlm.nih.gov/mesh/D005767Q000503 Gastrointestinal Diseases https://id.nlm.nih.gov/mesh/D005767 Tractus gastro-intestinal Maladies. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Gastrointestinal system Diseases fast Rajagopal, Senthilkumar, editor. Murugan, Sengottuvelan, editor. Ramachandran, Saravanan, editor. has work: Disorders of Gastrointestinal Systems and Clinical Manifestations (Text) https://id.oclc.org/worldcat/entity/E39PD3fGpMc7qRTDCqYwJhDqpP https://id.oclc.org/worldcat/ontology/hasWork Print version: Disorders of gastrointestinal systems and clinical manifestations. New York : Nova Biomedical, [2016] 9781634853668 (DLC) 2016940560 Digestive diseases--research and clinical developments series. http://id.loc.gov/authorities/names/n2010183264 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345681 Volltext |
spellingShingle | Disorders of gastrointestinal systems and clinical manifestations / Digestive diseases--research and clinical developments series. DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis 2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES RESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD) 1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP 5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES Gastrointestinal system Diseases Pathophysiology. Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Gastrointestinal Diseases physiopathology https://id.nlm.nih.gov/mesh/D005767Q000503 Gastrointestinal Diseases https://id.nlm.nih.gov/mesh/D005767 Tractus gastro-intestinal Maladies. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Gastrointestinal system Diseases fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85053488 https://id.nlm.nih.gov/mesh/D005767Q000503 https://id.nlm.nih.gov/mesh/D005767 |
title | Disorders of gastrointestinal systems and clinical manifestations / |
title_auth | Disorders of gastrointestinal systems and clinical manifestations / |
title_exact_search | Disorders of gastrointestinal systems and clinical manifestations / |
title_full | Disorders of gastrointestinal systems and clinical manifestations / Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors. |
title_fullStr | Disorders of gastrointestinal systems and clinical manifestations / Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors. |
title_full_unstemmed | Disorders of gastrointestinal systems and clinical manifestations / Senthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors. |
title_short | Disorders of gastrointestinal systems and clinical manifestations / |
title_sort | disorders of gastrointestinal systems and clinical manifestations |
topic | Gastrointestinal system Diseases Pathophysiology. Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Gastrointestinal Diseases physiopathology https://id.nlm.nih.gov/mesh/D005767Q000503 Gastrointestinal Diseases https://id.nlm.nih.gov/mesh/D005767 Tractus gastro-intestinal Maladies. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Gastrointestinal system Diseases fast |
topic_facet | Gastrointestinal system Diseases Pathophysiology. Gastrointestinal system Diseases. Gastrointestinal Diseases physiopathology Gastrointestinal Diseases Tractus gastro-intestinal Maladies. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Gastrointestinal system Diseases |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345681 |
work_keys_str_mv | AT rajagopalsenthilkumar disordersofgastrointestinalsystemsandclinicalmanifestations AT murugansengottuvelan disordersofgastrointestinalsystemsandclinicalmanifestations AT ramachandransaravanan disordersofgastrointestinalsystemsandclinicalmanifestations |